Here are the details of the trades Chris Johnson shared with you today…
Archives for April 2018
April 2018 - Page 4 of 19 - Money Morning - Only the News You Can Profit From
Financial Institutions Are Ready to Enter the $395 Billion Cryptocurrency Market
More institutions want to get in on the $395 billion cryptocurrency market.
In a recent survey, one in five financial firms said it plans to trade crypto in 2018.
And with more demand, the price of Bitcoin, Litecoin, and Ethereum could surge...
How Much Will Aramco Stock Be?
With a potential valuation of $2 trillion, even a 5% stock offering could be enough to shatter records.
Those sorts of numbers mean investors already want to know the price of Aramco stock once it goes public.
But investors don't have to wait for the IPO to start banking profits...
Dow Jones Today Opens Flat as Boeing Smashes Earnings Estimates
The Dow Jones today traded nearly 20 points off of Tuesday's close in pre-market trading despite a stellar earnings report from aviation giant Boeing Co. Boing beat earnings forecasts by 41% has already increased annual revenue by 5% over last year.
Get Your Hands on the World's First $1 Billion Cannabis Drug
When it comes to biotech, Wall Street tends to overreact. Though there's no reason for it to be there, biotech is in the dog house, and investors have been conditioned to punish the sector and its stocks whenever the opportunity presents itself.
You see, there are three main reasons biotech is down: Wall Street is worried about high and rising drug prices, the impact of a possible trade war on foreign sales, and expiring patents for some older medications.
Over the last several years, for example, I've read a number of Wall Street reports about the so-called "biotech patent cliff." Simply stated, a drug falls off that "cliff" when its patent runs out and it starts facing competition from generics.
And a number of successful drugs out there are rapidly approaching their patent cliffs.
That sounds bad.
But there are good things happening in biotech, as well. In fact, what you don't hear much about is that the industry is about to bust out.
For example, I was thrilled to see a recent report from Clarivant Analytics, a research firm that works closely with industry leaders and top universities, which says a total of 12 compounds being released in 2018 could become blockbusters.
So I went through the data and found one ultimate biotech blockbuster that I think could lead the pack.
Will We See a Bear Market in 2018?
The Dow is down over 1% on the year; it plunged more than 1,000 points on Feb. 5 and hasn't rallied back to January highs.
That could be a sign we'll see a bear market in 2018.
Litecoin Proves Cryptocurrencies Can Disrupt the Global Banking Sector
A lot of cryptocurrency enthusiasts were shocked that there was $99 million worth of Litecoin sent in a single transaction on April 19.
But what really caught our attention was that it only took two and a half minutes and cost just $0.40.
Why the Price of Silver Is So Volatile, and Where It's Headed Next
The price of silver had a volatile week, climbing all the way to $17.31 on Thursday (April 19), before settling back down below $17 yesterday (Monday).
Because of that volatility, I'm going to show you today exactly where I see the price of silver heading in both the short term and the long term.
But first, we need to look at exactly why silver prices reversed course last week.
Using the "Straddle" and "Strangle" to Profit from Volatility
Earnings season brings swings up and down that are impossible to predict.
But we've got two options strategies you can use to make quick money on movement in either direction.
Learn all about how to use the straddle and the strangle.
John McAfee to Jamie Dimon: Your Plot to End Crypto Has Failed
Software expert and crypto guru John McAfee has had a longstanding beef with JPMorgan CEO Jamie Dimon.
Now, McAfee has accused Dimon of trying to end crypto altogether.
But here's the kicker: Dimon might be trying to do just the opposite...